Lisen collaborated with the Lankenau Institute of Medical Research (LIMR) for the research of imprinted genes related to early lung cancer diagnosis. 

LIMR was one of the first US research institutes to focus on cancer when it was founded in 1927. It continues to serve as a non-profit, biomedical research institute located on the campus of Lankenau Medical Center in Wynnewood, Pennsylvania, functioning as the research division of the Main Line Health System in Philadelphia. LIMR focuses on studies of cancer, cardiovascular, autoimmune, gastrointestinal and other diseases. The institute has four hospitals with more than 2,000 physicians, including a roster of esteemed medical researchers in the fields of immunology, oncology and cardiology. LIMR’s principal investigators are devoted to advancing innovative new approaches to formidable medical challenges, and using their basic, preclinical, clinical and translational research to support the clinical application and commercialization of the most advanced technologies.

Lisen collaborated with Shanghai Tenth People's Hospital for the research of imprinted genes related to early thyroid cancer diagnosis. 

The Department of Medical Ultrasound, also known as the Thyroid Research Center of Shanghai or the Thyroid Disease Diagnosis and Treatment Center, is a newly established multidisciplinary institute specializing in the integration of medical treatment, education and scientific research on various thyroid diseases including tumors, Hashimoto's thyroiditis and hyperthyroidism, among others. The center is also capable of conducting fine needle aspiration of the thyroid gland, minimally invasive thyroid surgery, radical thyroidectomy and total endoscopy, as well as, thyroid surgery, postoperative isotope treatment of thyroid cancer and thyroid genetic testing.

Lisen collaborated with Zhongshan Hospital for the research of imprinted genes related to early thyroid and lung cancer diagnosis.  

Zhongshan Hospital is a subsidiary unit of the National Health and Family Planning Commission, and is affiliated with Fudan University. The hospital opened in 1937 and was the first large-scale Chinese medical institution at that time. Initially named as the Sun Yat Sen Memorial Hospital, it was previously affiliated with the National Shanghai Medical College. It was recognized as one of the first batch of Class A hospitals in Shanghai by the Ministry of Health in 1991.

Lisen collaborated with the Second Hospital of Dalian Medical University for the research of imprinted genes related to early lung cancer diagnosis. 

The Second Hospital of Dalian Medical University (Affiliated Cancer Hospital) was founded in 1958. It is a large-scale, provincial III-A hospital that integrates medical treatment, teaching, scientific research and health management. It is also a national regional medical center for cancer. The hospital is one of the first pilot units in China to establish and improve the modern hospital management system. It is the first hospital in Northeast China to pass the five-star certification of Chinese hospital competitiveness, and has been ranked among the top 100 national top hospitals for several consecutive times.

Lisen collaborated with Sichuan Cancer Hospital & Institute for the research of imprinted genes related to early thyroid cancer and skin cancer diagnosis. 

Sichuan Cancer Hospital & Institute is affiliated to the School of Medicine, UESTC. It was established in the 1980s and is III-A hospital (the highest level in Chinese hospital hierarchy) which specializes in oncology. The hospital is also in the national key clinical projects in oncology. The hospital is the largest cancer hospital with cancer treatment, prevention, research, education, training and rehabilitation in Southwest China. The hospital has internal affiliations with cancer centers all over the world including Saint Petersburg Cancer Center, Institute University Hospital Maggiore della Carita, Gustave Roussy (IGR), Health Department of Duke University and Huntsman Cancer Hospital of Utah University.

Lisen collaborated with the West China Second University Hospital of Sichuan University (WCSUH- SCU) for the research of imprinted genes related to cervical cancer diagnosis. 

The WCSUH-SCU, also known as West China Women’s and Children’s Hospital, Sichuan University, is directly supervised by the National Health Commission of China. It originated from the Renji Women’s Hospital that was set up in 1896. In 1987, the hospital was established on the basis of the Department of Obstetrics and Gynecology and the Department of Pediatrics in the University Hospital of the former West China University of Medical Sciences. After the merger of West China University of Medical Sciences and Sichuan University, the hospital has taken its present name. The hospital was one of the first national top tertiary hospitals and serves as a medical center for women and children in Southwestern China. It plays an important role in medical service, education, research, disease prevention and healthcare. 

Lisen collaborated with the Zhongda Hospital Southeast University for the research of imprinted genes related to early lung cancer diagnosis. 

It was founded in 1935 and has since developed into a large-scale and comprehensive medical institution integrating medical treatment, education and scientific research. It is the only university-affiliated hospital in Jiangsu Province involved with the '985' and '211' projects directly managed by the Jiangsu Ministry of Education. It is also the only Level III hospital in the province as approved by the Ministry of Health.

Lisen collaborated with Jiangyuan Hospital for the research of imprinted genes related to early thyroid cancer diagnosis. 

The hospital is affiliated with the Jiangsu Institute of Atomic Medicine, Clinical Department of the Ministry of Health's Nuclear Medicine Laboratory, and the Jiangsu Provincial People's Hospital. It established the Wuxi City Thyroid Disease Institute in 2010 as approved by the Wuxi Municipal Health Bureau.

Lisen collaborated with the Chinese Alliance Against Lung Cancer (CAALC) for the research of imprinted genes related to early lung cancer diagnosis. 

The CAALC organization was formally established in 2012 at the China Lung Cancer Prevention and Treatment Alliance - American College of Chest Physicians (ACCP) - Shanghai Lung Science Association Meeting. Fudan University professor Chunxue Bai, who was also the director of Shanghai Institute of Respiratory Diseases and Department of Respiratory Medicine of Zhongshan Hospital, served as the CAALC chairman, while Nanshan Zhong of the Chinese Academy of Engineering served as the honorary chairman.

Lisen collaborated with the Shanghai Institute of Respiratory Diseases for the research of imprinted genes related to early lung cancer diagnosis. 

The institute was established in 2012 at Zhongshan Hospital Fudan University, comprising five innovative laboratories, namely the Pulmonary Infection Laboratory, Clinical Respiratory Physiology Laboratory, Biophysical Laboratory, Cell and Molecular Biology Laboratory, Internet of Things Medical Laboratory. With focus on respiratory infections, chronic airway diseases and lung cancer, the institute explores the key issues in the prevention and treatment of these diseases through its innovation-led research on pathogenesis.